Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (181-190 of 340) with videos related to

Pageof 34
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesisEmile M Youssef, Dafna Lotan, Jean-Pierre Issa, et al.
Neoplasia (New York, N.Y.)|April 1, 2005
Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaVemparala Subbarayan, Xiao-Chun Xu, Jeri Kim, et al.
Oncotarget|February 17, 2016
A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancersKosuke Yamaguchi, Ramiro Iglesias-Bartolomé, Zhiyong Wang, et al.
Cancer Research|July 12, 2019
Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating CellsXingyu Wu, Huwate Yeerna, Yusuke Goto, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
High-dose fenretinide in oral leukoplakiaWilliam N William, J Jack Lee, Scott M Lippman, et al.
NPJ Precision Oncology|September 22, 2022
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapyBryan H Louie, Shumei Kato, Ki Hwan Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancyVassiliki A Papadimitrakopoulou, J Jack Lee, William N William, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in UrineHatim Husain, Vladislava O Melnikova, Karena Kosco, et al.
Pageof 34

Showing results (181-190 of 340) with videos related to

Sort By:
Pageof 34
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2006
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trialZhihong Gong, Marian L Neuhouser, Phyllis J Goodman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesisEmile M Youssef, Dafna Lotan, Jean-Pierre Issa, et al.
Neoplasia (New York, N.Y.)|April 1, 2005
Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaVemparala Subbarayan, Xiao-Chun Xu, Jeri Kim, et al.
Oncotarget|February 17, 2016
A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancersKosuke Yamaguchi, Ramiro Iglesias-Bartolomé, Zhiyong Wang, et al.
Cancer Research|July 12, 2019
Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating CellsXingyu Wu, Huwate Yeerna, Yusuke Goto, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
High-dose fenretinide in oral leukoplakiaWilliam N William, J Jack Lee, Scott M Lippman, et al.
NPJ Precision Oncology|September 22, 2022
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapyBryan H Louie, Shumei Kato, Ki Hwan Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancyVassiliki A Papadimitrakopoulou, J Jack Lee, William N William, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 9, 2016
Transforming Cancer Prevention through Precision Medicine and Immune-oncologyThomas W Kensler, Avrum Spira, Judy E Garber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2017
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in UrineHatim Husain, Vladislava O Melnikova, Karena Kosco, et al.
Pageof 34